Serum Institute explores new-age vaccine delivery systems for growth

The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems

Having delivered billions of doses of Covid-19 vaccines to the world, Pune’s Serum Institute of India (SII) is now working on the next leg of growth. Besides building a pandemic facility of 2 billion annual doses, the privately held firm has begun work on the new-age vaccine delivery systems.

Delivery of vaccines using newer technologies such as skin patches and high speed jets are likely to gain traction in the coming years. Administering vaccines through the oral and nasal route are also likely to gain popularity over the traditional needle route for the ease of use, and less discomfort